The incidence of cardiovascular disease is rising across the globe, with more than 28 million people worldwide living with ...

Compare TAVR and redo open heart surgery for aortic valve stenosis, including risks, recovery, valve longevity, and how to ...

A $10 billion transcatheter aortic valve replacement (TAVR) market can still be an underdeveloped disease category. Aortic ...

Data on valve durability with transcatheter aortic valve replacement are reassuring at 7 years, with implications for ...

EW heads into Q2 earnings results with estimates calling for double-digit revenue growth as TAVR, TMTT and Surgical heart ...

The new framework removes the requirement for coverage with evidence determination (CED) for TAVR in patients with symptomatic severe aortic valve stenosis and extends coverage to asymptomatic aortic ...

Discover how TAVR Mumbai is transforming cardiac care. Learn about the surge in Transcatheter Aortic Valve Replacement procedures ...

Dr A. Sreenivas Kumar, senior consultant cardiologist and director of cardiology and clinical research, said severe AS, ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Successful PCI and TAVR for High Coronary Artery Obstruction Risk in a Patient With Protruding Left Main Coronary Artery Stent Receive the the latest news, research, and presentations from major ...

SAN FRANCISCO--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced seven-year data from the PARTNER 3 trial, reaffirming the early and sustained patient benefits of Edwards TAVR. The data ...

New Evidence Further Defines Distinct Clinical Considerations for Transcatheter Aortic Valve Replacement (TAVR) in Aortic Regurgitation (AR) and Advances Understanding of the Trilogy® System in Patien ...